SLDB Operating Cash Flow (Statement)
Solid Biosciences Inc · Operating Cash Flow (Statement)
SLDB Operating Cash Flow (Statement)
Latest reported-$52.59Mperiod ending
SLDB Quarterly Cash from Operations (-$5.57M → -$52.59M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
SLDB operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -52,587,000 | |
| -47,230,000 | |
| -53,555,000 | |
| -33,472,000 | |
| -37,412,000 | |
| -31,850,000 | |
| -29,645,000 | |
| -23,708,000 | |
| -21,467,000 | |
| -25,192,000 | |
| -20,823,000 | |
| -17,897,000 | |
| -27,465,000 | |
| -27,995,000 | |
| -34,480,000 | |
| -20,429,000 | |
| -15,878,000 | |
| -27,190,000 | |
| -20,874,000 | |
| -18,424,000 | |
| -17,100,000 | |
| -21,366,000 | |
| 1,307,000 | |
| -15,564,000 | |
| -13,068,000 | |
| -29,274,000 | |
| -21,245,000 | |
| -19,241,000 | |
| -26,301,000 | |
| -25,927,000 | |
| -21,404,000 | |
| -15,290,000 | |
| -16,331,000 | |
| -17,172,000 | |
| -13,982,000 | |
| -9,439,000 | |
| -9,607,000 | |
| -10,196,000 | |
| -5,574,000 |